2025 · 3rd Quarter (July 1 - Sep 30)

INFUSION PROVIDERS ALLIANCE

Filed by INFUSION PROVIDERS ALLIANCE.

Open official filing

Source-reported fields

Filing overview

Type: 3rd Quarter - Report
Posted: Oct 20, 2025
Income: Not reported
Expenses: $110,000.00
Registrant: INFUSION PROVIDERS ALLIANCE
Client: INFUSION PROVIDERS ALLIANCE
Filing UUID: d8bf8abf-b67b-450c-847e-1331c9907ee8
Termination date: Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to physician reimbursement for Part B drugs. Issues related to virtual supervision of infusion drugs. Issues related to physician reimbursement to complex drug administration. Issues related to appropriate reimbursement for administration of Part B drugs. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act Issues related to the 2026 Medicare Physician Fee Schedule Proposed Rule (CMS-1832-P).

Literal federal measure citations: H.R. 4299

HCR · Health Issues

Advocating for access to and reimbursement for biosimilars.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.